GMP peptide active pharmaceutical ingredient supply
GMP-manufactured peptide drug substance for clinical trials and commercial demand under a quality system aligned to ICH and regional GMP expectations. Scope is drug substance—synthesis, purification, isolation, release and stability—not discovery-grade custom work.
GMP
quality system
Batch
MRB + QP release (region-dependent)
kg
campaign scale (typical band)
ICH
stability commitment
DMF
support (sponsor-led)
GMP peptide API scope
Programs supply peptide active pharmaceutical ingredient with validated or GMP-qualified analytical methods, approved specifications and batch records under change control.
Technology transfer from NCE development or a sponsor route packages critical process parameters, impurity controls and cleaning verification into commercial manufacturing.
GMP campaign flow
Tech transfer and PPQ planning
Engineering batch, risk assessment, cleaning and equipment qualification as per quality plan.
Raw material qualification
Amino acids, resins and solvents to agreed standards; vendor qualification on file.
GMP manufacture
Documented SPPS, cleavage, purification and isolation with in-process controls.
QC release
Full specification testing; deviation and OOS management per SOP.
Stability and distribution
Ongoing stability; COA per shipment; cold chain when required.
Documentation package (typical)
- Certificate of analysis and certificate of conformance
- Executed batch record summary
- Specification and method references (sponsor-accessible)
- Stability data per commitment protocol
- MSDS and safety information
- Regulatory support letters for DMF / ASMF cross-reference (as contracted)
Typical GMP release tests
| Feature | Test | Clinical API | Commercial API |
|---|---|---|---|
| Appearance | Yes | Yes | |
| Identity (MS / peptide map) | Yes | Yes | |
| Purity (HPLC) | Yes | Yes | |
| Peptide content | Yes | Yes | |
| Specified impurities | Qualified list | Fully validated limits | |
| Water / residual solvents | Yes | Yes | |
| Microbial limits / endotoxin | Per route | Per route and claim | |
| Sterility | If non-sterile DS | If non-sterile DS |
Sponsor phase alignment
Manufacturing readiness tracks clinical phase; PPQ precedes commercial launch.
Clinical (Ph I–II)
Manufacturing
First GMP batches; may use developing specs
Analytics
Qualified release methods
Regulatory
IND cross-reference to drug substance supplier
Pivotal (Ph III)
Manufacturing
Consistent scale; comparability after changes
Analytics
Validated impurity methods
Stability
Primary batches on long-term stability
PPQ / Launch
Manufacturing
Three consecutive successful lots (typical PPQ pattern)
Analytics
Reference standard requalification
Regulatory
Marketing authorization CMC support
Frequently asked questions
GMP API requires validated processes, qualified equipment, full batch documentation and release against an approved specification under a pharmaceutical quality system.
Related
Peptide NCE / CMC Development
Process and analytical development that connects research synthesis to a repeatable drug substance story: route selection, impurity fate, specification rationale and stability—structured phase by phase from preclinical supply through commercial readiness.
View detailsGeneric Peptide APIs
Drug substance for approved peptide NCEs—long GLP-1 analogs, somatostatin analogs and GnRH agonists—supplied with analytics suited to generic dossiers. Routes emphasize scalable SPPS or hybrid manufacturing and impurity control against patent-expired reference products.
View detailsCustom Peptide Synthesis
Solid-phase and solution synthesis of linear and modified peptides for discovery, assay development and lead optimization. Scale, purity tier and QC depth are matched to how the material will be used—not every program needs the same finishing step.
View detailsAmino Acid Derivatives
Fmoc and Boc protected amino acids, pseudoproline dipeptides, phosphorylated and unnatural derivatives, and pre-activated forms for SPPS. Lot-enantiomeric purity at the monomer propagates into the final peptide—especially on long sequences.
View detailsReady to specify this for your program?
Share sequence, scale and documentation needs. We reply with indicative specs and a project-specific quotation.